Paul F. Truex, Director at Trius Therapeutics Inc (TSRX), bought 2,000 shares at $6.80 ($14K) on 2011-08-29, disclosed to the SEC on 2011-08-31.
Open-market purchase of $14k TSRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ANTH | BUY | 2012-07-02 | $15K | — | Filing → |
| ANTH | SELL | 2012-02-17 | $118K | — | Filing → |
| ANTH | SELL | 2012-01-19 | $101K | — | Filing → |